Eisai
4523.T
#1974
Rank
S$10.52 B
Marketcap
$37.31
Share price
0.44%
Change (1 day)
-30.34%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $2.96

According to Eisai's latest financial reports the company's current EPS (TTM) is $2.87. In 2022 the company made an earnings per share (EPS) of $2.11 a decrease over its 2021 EPS that were of $9.36.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.9640.44%
2022$2.11-77.48%
2021$9.36-41.88%
2020$16.10-0.94%
2019$16.2552.59%
2018$10.65124.17%
2017$4.75-49.42%
2016$9.3937.08%
2015$6.85-11.75%
2014$7.77-3.23%
2013$8.02-18.56%
2012$9.85-15.51%
2011$11.66-3.75%
2010$12.12-1.36%
2009$12.28